“Efficacy and Safety of Sofosbuvir and Ribavirin in Treatment of Chronic Hepatitis C Infection G3 of Multi-Transfused Children Aged 4 To 12 Years; A Single Center Study ”, mfm, vol. 34, no. 7, Aug. 2023, doi: 10.60110/medforum.340737.